We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluating the Effectiveness and Outcomes of Silicone Breast Prosthetics

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00594490
Recruitment Status : Active, not recruiting
First Posted : January 15, 2008
Last Update Posted : November 14, 2012
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
This trial will evaluate the outcome of placement of silicone breast prosthetics.

Condition or disease
Breast Cancer

Detailed Description:
Patients will be evaluated for complications following placement of silicone breast prostheses.

Study Design

Study Type : Observational
Actual Enrollment : 20 participants
Time Perspective: Prospective
Official Title: Adjunct Study for Silicone Gel-Filled Mammary Prosthesis
Study Start Date : January 2001
Estimated Primary Completion Date : January 2025
Estimated Study Completion Date : January 2025

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort
Silicone
patients undergoing placement of silicone breast prosthetics


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
women undergoing breast reconstruction
Criteria

Inclusion Criteria:

  • over 18 undergoing breast reconstruction

Exclusion Criteria:

  • patients with collagen vascular diseases, rheumatoid arthritis, scleroderma, etc.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00594490


Locations
United States, California
The University of California, Irvine
Orange, California, United States, 92868
Sponsors and Collaborators
University of California, Irvine
Mentor Worldwide, LLC
Investigators
Principal Investigator: Gregory Evans The University of California, Irvine
More Information

Responsible Party: Gregory R. Evans, Professor, University of California, Irvine
ClinicalTrials.gov Identifier: NCT00594490     History of Changes
Other Study ID Numbers: 2001-2192
First Posted: January 15, 2008    Key Record Dates
Last Update Posted: November 14, 2012
Last Verified: November 2012

Keywords provided by Gregory R. Evans, University of California, Irvine:
Breast, reconstruction, silicone